Conference Calendar - The 33rd International Papillomavirus Conference

Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.

To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform.

Displaying One Session

View

Public Health Oral Session

00730 - Oral Session 7: VACCINATION III. Implementation, dissemination, and communication (ID 69)

Session Type

Public Health Oral Session

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Chair(s)

Marc Steben (Canada)

Watch Stream
Session Webcast

Session Webcast

[{"name":"DEVELOPMENT AND EVALUATION OF AN ONLINE CONTINUING EDUCATION MODULE TO INCREASE HEALTHCARE PROVIDER SELF-EFFICACY TO MAKE STRONG HPV VACCINE RECOMMENDATIONS TO EAST AFRICAN IMMIGRANT FAMILIES \u003Csmall\u003E(ID 603)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":603,"presentation":"DEVELOPMENT AND EVALUATION OF AN ONLINE CONTINUING EDUCATION MODULE TO INCREASE HEALTHCARE PROVIDER SELF-EFFICACY TO MAKE STRONG HPV VACCINE RECOMMENDATIONS TO EAST AFRICAN IMMIGRANT FAMILIES \u003Csmall\u003E(ID 603)\u003C\/small\u003E","session":"Oral Session 7: VACCINATION III. Implementation, dissemination, and communication","presenter":"Rachel L. Winer (United States of America)","photo":""},"playlist":[{"name":"DEVELOPMENT AND EVALUATION OF AN ONLINE CONTINUING EDUCATION MODULE TO INCREASE HEALTHCARE PROVIDER ","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/Rachel Winer - IPVC20 - PRESENTATION id 603.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/69\/Rachel Winer - IPVC20 - PRESENTATION id 603.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/96388DCA.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/Rachel Winer - IPVC20 - PRESENTATION id 603.vtt"}]},{"name":"HPV VACCINATION RATES IN A RANDOMIZED TRIAL EVALUATING A SOCIAL MEDIA CAMPAIGN WITH MOTHERS OF DAUGHTERS AGED 14-17 IN THE USA \u003Csmall\u003E(ID 645)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":645,"presentation":"HPV VACCINATION RATES IN A RANDOMIZED TRIAL EVALUATING A SOCIAL MEDIA CAMPAIGN WITH MOTHERS OF DAUGHTERS AGED 14-17 IN THE USA \u003Csmall\u003E(ID 645)\u003C\/small\u003E","session":"Oral Session 7: VACCINATION III. Implementation, dissemination, and communication","presenter":"David Buller (United States of America)","photo":""},"playlist":[{"name":"HPV VACCINATION RATES IN A RANDOMIZED TRIAL EVALUATING A SOCIAL MEDIA CAMPAIGN WITH MOTHERS OF DAUGH","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/David Buller 645.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/69\/David Buller 645.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/FCB13EA8.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/David Buller 645.vtt"}]},{"name":"EVALUATING THE IMPLEMENTATION OF AN HPV VACCINE SCHOOL ENTRY REQUIREMENT POLICY USING PROVIDER-VERIFIED DATA \u003Csmall\u003E(ID 496)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":496,"presentation":"EVALUATING THE IMPLEMENTATION OF AN HPV VACCINE SCHOOL ENTRY REQUIREMENT POLICY USING PROVIDER-VERIFIED DATA \u003Csmall\u003E(ID 496)\u003C\/small\u003E","session":"Oral Session 7: VACCINATION III. Implementation, dissemination, and communication","presenter":"Gregory Zimet (United States of America)","photo":""},"playlist":[{"name":"EVALUATING THE IMPLEMENTATION OF AN HPV VACCINE SCHOOL ENTRY REQUIREMENT POLICY USING PROVIDER-VERIF","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/496.Gregory Zimet.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/69\/496.Gregory Zimet.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/925339F4.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/496.Gregory Zimet.vtt"}]},{"name":"HIGH VACCINE EFFECTIVENESS AGAINST PERSISTENT INFECTIONS UP TO EIGHT YEARS POST THREE DOSES OF BIVALENT HPV VACCINATION IN THE NETHERLANDS \u003Csmall\u003E(ID 715)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":715,"presentation":"HIGH VACCINE EFFECTIVENESS AGAINST PERSISTENT INFECTIONS UP TO EIGHT YEARS POST THREE DOSES OF BIVALENT HPV VACCINATION IN THE NETHERLANDS \u003Csmall\u003E(ID 715)\u003C\/small\u003E","session":"Oral Session 7: VACCINATION III. Implementation, dissemination, and communication","presenter":"Joske Hoes (Netherlands)","photo":""},"playlist":[{"name":"HIGH VACCINE EFFECTIVENESS AGAINST PERSISTENT INFECTIONS UP TO EIGHT YEARS POST THREE DOSES OF BIVAL","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/GMT20200526-100012_Zoom-Recor_1920x1080.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/69\/GMT20200526-100012_Zoom-Recor_1920x1080.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/55F3A9BE.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/GMT20200526-100012_Zoom-Recor_1920x1080.vtt"}]},{"name":"STRONG REDUCTION IN PREVALENCE OF HPV 16\/18 AND CLOSELY RELATED HPV TYPES IN SEXUALLY ACTIVE ADOLESCENT WOMEN FOLLOWING THE INTRODUCTION OF HPV VACCINATION IN ARGENTINA. \u003Csmall\u003E(ID 163)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":163,"presentation":"STRONG REDUCTION IN PREVALENCE OF HPV 16\/18 AND CLOSELY RELATED HPV TYPES IN SEXUALLY ACTIVE ADOLESCENT WOMEN FOLLOWING THE INTRODUCTION OF HPV VACCINATION IN ARGENTINA. \u003Csmall\u003E(ID 163)\u003C\/small\u003E","session":"Oral Session 7: VACCINATION III. Implementation, dissemination, and communication","presenter":"Rita M. Correa (Argentina)","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/ipvc20\/persons\/photos\/1791.jpg"},"playlist":[{"name":"STRONG REDUCTION IN PREVALENCE OF HPV 16\/18 AND CLOSELY RELATED HPV TYPES IN SEXUALLY ACTIVE ADOLESC","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/Rita Mariel Correa - IPVC20 - Presentation 163.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/69\/Rita Mariel Correa - IPVC20 - Presentation 163.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/521160.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/Rita Mariel Correa - IPVC20 - Presentation 163.vtt"}]},{"name":"EFFECTIVENESS AND COST-EFFECTIVENESS OF POINT-OF-CARE HPV-DNA TESTING AND SAME-DAY TREATMENT IN THE HIGH-BURDEN, LOW-RESOURCE SETTING OF PAPUA NEW GUINEA \u003Csmall\u003E(ID 981)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":981,"presentation":"EFFECTIVENESS AND COST-EFFECTIVENESS OF POINT-OF-CARE HPV-DNA TESTING AND SAME-DAY TREATMENT IN THE HIGH-BURDEN, LOW-RESOURCE SETTING OF PAPUA NEW GUINEA \u003Csmall\u003E(ID 981)\u003C\/small\u003E","session":"Oral Session 7: VACCINATION III. Implementation, dissemination, and communication","presenter":"Diep Thi Ngoc Nguyen (Australia)","photo":""},"playlist":[{"name":"EFFECTIVENESS AND COST-EFFECTIVENESS OF POINT-OF-CARE HPV-DNA TESTING AND SAME-DAY TREATMENT IN THE ","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/2nd Recording NEW _Diep Nguye IPVC 20 p 981.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/69\/2nd Recording NEW _Diep Nguye IPVC 20 p 981.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/B1EB592E.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/69\/2nd Recording NEW _Diep Nguye IPVC 20 p 981.vtt"}]}]

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

DEVELOPMENT AND EVALUATION OF AN ONLINE CONTINUING EDUCATION MODULE TO INCREASE HEALTHCARE PROVIDER SELF-EFFICACY TO MAKE STRONG HPV VACCINE RECOMMENDATIONS TO EAST AFRICAN IMMIGRANT FAMILIES (ID 603)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

11:35 - 11:47

Presenter

Rachel L. Winer (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

HPV VACCINATION RATES IN A RANDOMIZED TRIAL EVALUATING A SOCIAL MEDIA CAMPAIGN WITH MOTHERS OF DAUGHTERS AGED 14-17 IN THE USA (ID 645)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

11:47 - 11:59

Presenter

David Buller (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

EVALUATING THE IMPLEMENTATION OF AN HPV VACCINE SCHOOL ENTRY REQUIREMENT POLICY USING PROVIDER-VERIFIED DATA (ID 496)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

11:59 - 12:11

Presenter

Gregory Zimet (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

HIGH VACCINE EFFECTIVENESS AGAINST PERSISTENT INFECTIONS UP TO EIGHT YEARS POST THREE DOSES OF BIVALENT HPV VACCINATION IN THE NETHERLANDS (ID 715)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

12:11 - 12:23

Presenter

Joske Hoes (Netherlands)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

STRONG REDUCTION IN PREVALENCE OF HPV 16/18 AND CLOSELY RELATED HPV TYPES IN SEXUALLY ACTIVE ADOLESCENT WOMEN FOLLOWING THE INTRODUCTION OF HPV VACCINATION IN ARGENTINA. (ID 163)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

12:23 - 12:35

Presenter

Rita M. Correa (Argentina)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

THE IMPACT OF A UNIVERSAL HPV VACCINATION PROGRAM ON LOWER GENITAL TRACT DYSPLASIA AND GENITAL WARTS (ID 316)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

12:35 - 12:47

Presenter

Mitchell Clark (Canada)

Authors

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

EFFECTIVENESS AND COST-EFFECTIVENESS OF POINT-OF-CARE HPV-DNA TESTING AND SAME-DAY TREATMENT IN THE HIGH-BURDEN, LOW-RESOURCE SETTING OF PAPUA NEW GUINEA (ID 981)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

12:47 - 12:59

Presenter

Diep Thi Ngoc Nguyen (Australia)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication Hall F

Online Chat Q&A for this session is called: PUBLIC HEALTH ORAL SESSION 7: VACCINATION III. IMPLEMENTATION, DISSEMINATION, AND COMMUNICATION. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1822)

Session Date

07/22/2020

Session Time

11:35 - 13:00

Room

Hall F

Session Type

Public Health Oral Session

Session Name

Oral Session 7: VACCINATION III. Implementation, dissemination, and communication

Lecture Time

12:59 - 12:59